| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Revenue from license agreement | ||||||
- | - | - | - | - | 13,166 | 73,134 |
Operating expenses: | ||||||
General and administrative | ||||||
15,122 | 9,974 | 9,146 | 21,815 | 16,456 | - | - |
Marketing, general and administrative | ||||||
- | - | - | - | - | 3,469 | 8,065 |
Research and development | ||||||
22,457 | 22,362 | 17,948 | 31,317 | 18,991 | 11,527 | 26,455 |
Restructuring Charges | ||||||
- | - | 1,038 | 8,179 | - | - | - |
Total operating expenses | ||||||
37,579 | 32,336 | 28,132 | 61,311 | 35,447 | 14,996 | 34,520 |
Loss from operations | ||||||
-37,579 | -32,336 | -28,132 | -61,311 | -35,447 | -1,830 | 38,614 |
Other income, net | ||||||
1,543 | 1,044 | 716 | 547 | -300 | -5 | -1,209 |
Loss before income taxes | ||||||
-36,036 | -31,292 | -27,416 | -60,764 | -35,747 | -1,835 | 37,405 |
Provision for income taxes | ||||||
284 | -31 | -590 | 347 | 161 | 176 | 1,224 |
Net loss | ||||||
-36,320 | -31,261 | -26,826 | -61,111 | -35,908 | -2,011 | 36,181 |
Accretion of redeemable convertible preferred stock | ||||||
- | - | - | - | 318 | 904 | 3,034 |
Net loss attributable to common stockholders | ||||||
- | - | - | - | -36,226 | -2,915 | -5,357 |
Earnings per share | ||||||
Basic | ||||||
-1.06 | -1.28 | -1.10 | -2.51 | -3.25 | -66.21 | -125.29 |
Diluted | ||||||
-1.06 | -1.28 | -1.10 | -2.51 | -3.25 | -66.21 | -125.29 |
Weighted-average shares outstanding: | ||||||
Basic | ||||||
34,204 | 24,399 | 24,366 | 24,319 | 11,151 | 44 | 42 |
Diluted | ||||||
34,204 | 24,399 | 24,366 | 24,319 | 11,151 | 44 | 42 |